Report of Consensus Panel 5 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with intolerance or resistance to covalent BTK inhibitors.
Saved in:
| Title: | Report of Consensus Panel 5 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with intolerance or resistance to covalent BTK inhibitors. |
|---|---|
| Authors: | Castillo JJ; Bing Center for Waldenström Macroglobulinemia, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA. Electronic address: jorgej_castillo@dfci.harvard.edu., Autore F; Institute of Hematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Berinstein NL; Odette Cancer Centre, Sunnybrook Research Institute, Toronto, Canada., Branagan AR; Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA., Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece., Fernandez de Larrea C; Department of Hematology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain., Ferrero S; Department of Molecular Biotechnologies and Health Sciences, Division of Hematology, University of Torino, Torino, Italy., Kapoor P; Division of Hematology, Mayo Clinic, Rochester, MN., Kastritis E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece., Khwaja J; Department of Haematology, University College London Hospital, London, United Kingdom., Minnema MC; Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Qiu L; National Clinical Research Center for Hematological Diseases, State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China., Seymour JF; Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne, Melbourne, Victoria, Australia., Vos JMI; Department of Hematology, Amsterdam University Medical Center (A-UMC), University of Amsterdam, Amsterdam, The Netherlands., Patterson CJ; Bing Center for Waldenström Macroglobulinemia, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA., Buske C; Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany., Matous JV; Plasma Cell Diseases Group Colorado Blood Cancer Institute, Sarah Cannon Research Institute, Denver, CO., Treon SP; Bing Center for Waldenström Macroglobulinemia, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA., Palomba ML; Lymphoma Service, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY. |
| Source: | Seminars in hematology [Semin Hematol] 2025 Apr; Vol. 62 (2), pp. 113-119. Date of Electronic Publication: 2025 Apr 08. |
| Publication Type: | Consensus Statement; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0404514 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8686 (Electronic) Linking ISSN: 00371963 NLM ISO Abbreviation: Semin Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40379542 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Report of Consensus Panel 5 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with intolerance or resistance to covalent BTK inhibitors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Castillo+JJ%22">Castillo JJ</searchLink>; Bing Center for Waldenström Macroglobulinemia, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA. Electronic address: jorgej&#95;castillo@dfci.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Autore+F%22">Autore F</searchLink>; Institute of Hematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Berinstein+NL%22">Berinstein NL</searchLink>; Odette Cancer Centre, Sunnybrook Research Institute, Toronto, Canada.<br /><searchLink fieldCode="AU" term="%22Branagan+AR%22">Branagan AR</searchLink>; Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Dimopoulos+MA%22">Dimopoulos MA</searchLink>; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Fernandez+de+Larrea+C%22">Fernandez de Larrea C</searchLink>; Department of Hematology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ferrero+S%22">Ferrero S</searchLink>; Department of Molecular Biotechnologies and Health Sciences, Division of Hematology, University of Torino, Torino, Italy.<br /><searchLink fieldCode="AU" term="%22Kapoor+P%22">Kapoor P</searchLink>; Division of Hematology, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Kastritis+E%22">Kastritis E</searchLink>; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Khwaja+J%22">Khwaja J</searchLink>; Department of Haematology, University College London Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Minnema+MC%22">Minnema MC</searchLink>; Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Qiu+L%22">Qiu L</searchLink>; National Clinical Research Center for Hematological Diseases, State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Seymour+JF%22">Seymour JF</searchLink>; Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Vos+JMI%22">Vos JMI</searchLink>; Department of Hematology, Amsterdam University Medical Center (A-UMC), University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Patterson+CJ%22">Patterson CJ</searchLink>; Bing Center for Waldenström Macroglobulinemia, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Buske+C%22">Buske C</searchLink>; Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Matous+JV%22">Matous JV</searchLink>; Plasma Cell Diseases Group Colorado Blood Cancer Institute, Sarah Cannon Research Institute, Denver, CO.<br /><searchLink fieldCode="AU" term="%22Treon+SP%22">Treon SP</searchLink>; Bing Center for Waldenström Macroglobulinemia, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Palomba+ML%22">Palomba ML</searchLink>; Lymphoma Service, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220404514%22">Seminars in hematology</searchLink> [Semin Hematol] 2025 Apr; Vol. 62 (2), pp. 113-119. <i>Date of Electronic Publication: </i>2025 Apr 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Consensus Statement; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22W%2EB%2E+Saunders%22">W.B. Saunders </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0404514 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-8686 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200371963%22">00371963 </searchLink><i>NLM ISO Abbreviation: </i>Semin Hematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40379542 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1053/j.seminhematol.2025.04.004 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 113 Titles: – TitleFull: Report of Consensus Panel 5 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with intolerance or resistance to covalent BTK inhibitors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Castillo JJ – PersonEntity: Name: NameFull: Autore F – PersonEntity: Name: NameFull: Berinstein NL – PersonEntity: Name: NameFull: Branagan AR – PersonEntity: Name: NameFull: Dimopoulos MA – PersonEntity: Name: NameFull: Fernandez de Larrea C – PersonEntity: Name: NameFull: Ferrero S – PersonEntity: Name: NameFull: Kapoor P – PersonEntity: Name: NameFull: Kastritis E – PersonEntity: Name: NameFull: Khwaja J – PersonEntity: Name: NameFull: Minnema MC – PersonEntity: Name: NameFull: Qiu L – PersonEntity: Name: NameFull: Seymour JF – PersonEntity: Name: NameFull: Vos JMI – PersonEntity: Name: NameFull: Patterson CJ – PersonEntity: Name: NameFull: Buske C – PersonEntity: Name: NameFull: Matous JV – PersonEntity: Name: NameFull: Treon SP – PersonEntity: Name: NameFull: Palomba ML IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2025 Apr Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1532-8686 Numbering: – Type: volume Value: 62 – Type: issue Value: 2 Titles: – TitleFull: Seminars in hematology Type: main |
| ResultId | 1 |
